Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial

BACKGROUND: The role of surgery in the management of patients with advanced gastrointestinal stromal tumors (GIST) in the era of imatinib mesylate (IM) remains debated. We analyzed the outcome of patients with non metastatic locally advanced primary GIST treated with IM within the prospective BFR14...

Descripción completa

Detalles Bibliográficos
Autores principales: Blesius, Aurore, Cassier, Philippe A, Bertucci, François, Fayette, Jerome, Ray-Coquard, Isabelle, Bui, Binh, Adenis, Antoine, Rios, Maria, Cupissol, Didier, Pérol, David, Blay, Jean-Yves, Le Cesne, Axel
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3052196/
https://www.ncbi.nlm.nih.gov/pubmed/21324142
http://dx.doi.org/10.1186/1471-2407-11-72

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3052196/
https://www.ncbi.nlm.nih.gov/pubmed/21324142
http://dx.doi.org/10.1186/1471-2407-11-72

Ejemplares similares